Found 14 matching trials
A Repeated-Dose Evaluation of Use of a Pain Relieving Drug and Safety of OROS Hydromorphone HCI in Patients With Chronic Cancer Pain PHASE3 The purpose of this repeated dose study is to develop recommended dosing in...
Show More Location
Multiple Locations
Learn More & Join Trial
A Randomized, Open-Label, Single-Dose, Small Study to Evaluate the Safety and Effectiveness of Hydromorphone in Patients With Short Term, Moderate to Severe Postoperative Pain PHASE2 The purpose of this small study was to investigate the safety and effective...
Show More Location
Multiple Locations
Learn More & Join Trial
Safety and Tolerability of Long-term Administration of OROS Hydromorphone HCI (Slow Release) in Cancer Pain PHASE3 The primary purpose of this study was to characterize the pain control achi...
Show More Location
Multiple Locations
Learn More & Join Trial
An Effectiveness, Safety and Quality of Life Measures With Hydromorphone HCL, Dilaudid CR (Controlled Release) PHASE3 The purpose of this study was to characterize the effectiveness and safety ...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study to Evaluate the Effectiveness and Safety of Slow Release Hydromorphone HCL for Treatment of Patients With Osteoarthritis PHASE3 The purpose of this study was to compare the analgesic (a drug that relieve...
Show More Location
Multiple Locations
Learn More & Join Trial
A Repeated-Dose Evaluation of a Pain Relieving Drug Use and Safety of OROS Hydromorphone HCI in Patients With Chronic Non-Malignant Pain PHASE3 The purpose of this repeated dose study is to develop recommended dosing in...
Show More Location
Multiple Locations
Learn More & Join Trial
Analgesic Response to Opioid Analgesics in Buprenorphine-Maintained Individuals NA The aim of this study is to examine the effects of opioid analgesics on acu...
Show More Location
UCLA Integrated Substance Abuse Programs Outpatient Clinical Research Center
Learn More & Join Trial
A Repeated Dose Study of the Metabolism and Action Evaluation of OROS Hydromorphone HCI (Slow Release) Tablets in Patients With Chronic Pain PHASE1 The purpose of this study was to characterize the steady-state pharmacokine...
Show More Location
Multiple Locations
Learn More & Join Trial
Safety, Effectiveness, and Impact on Quality of Life on Long-Term Administration of OROS Hydromorphone Slow-Release in Patients With Chronic Low Back Pain PHASE3 The purpose of this open-label, extension study is to characterize the safe...
Show More Location
Multiple Locations
Learn More & Join Trial
Safety and Tolerability of Long-Term Administration of Hydromorphone HCI CR (Controlled Release) PHASE3 The purpose of study was to characterize the safety and tolerability of lon...
Show More Location
Multiple Locations
Learn More & Join Trial